
|Articles|September 1, 1999
The American Journal of Managed Care
- September 1999
- Volume 5
- Issue 9
Is a Third-Trimester Antibody Screen in Rh+ Women Necessary?
Advertisement
Articles in this issue
almost 27 years ago
Drug Therapy of Allergic Rhinitisalmost 27 years ago
Rethinking Formulary Strategy: Management and Measurement ConsiderationsAdvertisement
Advertisement
Advertisement
Trending on AJMC
1
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
2
Paul Richardson, MD, Calls Mezigdomide “CAR T in a Pill” for Patients With R/R Multiple Myeloma
3
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
4
Teclistamab Outperforms Len/Dex in High-Risk Smoldering Myeloma With Higher CR Rate, PFS: Omar Nadeem, MD
5




